ctrl K

Watchlist Price Alert

NeuroSense Therapeutics L... (NRSNW)

NASDAQ: NRSNW · Real-Time Price · USD

0.85

0.00 (0.00%)

At close: Jun 17, 2025, 9:30 AM

NeuroSense Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	22K	97K	89K	n/a	n/a	n/a
Gross Profit	-22K	-97K	-89K	-3K	-3K	n/a
Operating Income	-9.9M	-12.05M	-13.55M	-5.59M	-2.89M	-1.24M
Interest Income	2K	178K	91K	n/a	61K	18K
Pretax Income	-10.21M	-11.28M	-12.34M	-4.04M	-2.83M	-1.22M
Net Income	-10.21M	-10.11M	-10.49M	-2.5M	-2.83M	-1.23M
Selling & General & Admin	4.18M	4.78M	7.14M	2.5M	393K	337K
Research & Development	5.7M	7.27M	6.42M	3.08M	2.5M	898K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	9.88M	12.05M	13.55M	5.59M	2.89M	1.24M
Interest Expense	311K	550K	15K	1.15M	n/a	5K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	9.9M	12.05M	13.55M	2.98M	2.89M	1.24M
Income Tax Expense	n/a	n/a	-1.14M	-1.55M	1K	5K
Shares Outstanding (Basic)	18.6M	13.64M	11.51M	1.94M	5.52M	1.94M
Shares Outstanding (Diluted)	18.6M	13.64M	11.51M	1.94M	5.52M	1.94M
EPS (Basic)	-0.55	-0.83	-0.97	-1.29	-1.46	-0.63
EPS (Diluted)	-0.55	-0.83	-0.97	-1.29	-1.46	-0.63
EBITDA	-9.88M	-9.64M	-13.38M	-2.88M	-2.83M	-1.25M
EBIT	-9.9M	-9.66M	-12.32M	-2.89M	-2.83M	-1.22M
Depreciation & Amortization	22K	97K	89K	3K	3K	1.24M